Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04927741
Other study ID # 20-221E (19-812)
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 27, 2021
Est. completion date March 2024

Study information

Verified date January 2024
Source Aurora Health Care
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will measure the effects of topical application of sweet marjoram essential oil + grapeseed oil with massage on uterine cramping/pain post-IUD insertion/placement. The intention is to conduct a pilot study that could give a first look at the data to determine whether this line of research is worth pursuing with more time, effort, and resources. The results of this pilot study will provide adequate data (e.g., variance estimates) needed for obtaining reasonably reliable sample size estimates if larger studies are warranted in the future.


Description:

Patients will be consented and randomized to one of three methods by a member of the study team on the day of their IUD insertion. Several variables of interest will be collected via the electronic medical record and via questionnaire.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date March 2024
Est. primary completion date May 26, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older at time of IUD insertion - English speaking - Subject has signed study-specific consent form - Subject has taken clinic recommended NSAID at least 30 minutes prior to IUD insertion Exclusion Criteria: - Subject is in post-partum period - Known allergies to sweet marjoram essential oil or grapeseed oil - Broken or irritated skin on lower abdomen - Diagnosis of IBS/IBD

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Sweet Marjoram Essential Oil
Subjects will receive a dilution of sweet marjoram essential oil (15 cc of grapeseed oil with 10 drops of sweet marjoram essential oil). Oil will be applied topically by the study medical providers. Providers will wear exam gloves, dip three fingers into the oil solution and apply it topically to the subject's lower abdomen. This will be applied by going left to right for 20 seconds while applying gentle pressure - counter pressure may be applied on the uterus to help relieve cramping.
Grapeseed Oil
Subjects will receive 15 cc of undiluted grapeseed oil. Oil will be applied topically by the study medical providers. Providers will wear exam gloves, dip three fingers into the oil solution and apply it topically to the subject's lower abdomen. This will be applied by going left to right for 20 seconds while applying gentle pressure - counter pressure may be applied on the uterus to help relieve cramping.

Locations

Country Name City State
United States Aurora BayCare Medical Center Green Bay Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
Aurora Health Care

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Pain/Discomfort as Assessed by NRS Pain/discomfort rating change following topical application of sweet marjoram + grapeseed oil with massage after IUD insertion. (Pain/discomfort assessed by NRS on scale of 0-10). 15 minutes post oil application/massage
Secondary NRS Patient Pain Rating The secondary objective of this study is to determine = 0.5-point different in perceived pain rating (on a scale of 0-10) exists between Method 1 (sweet marjoram essential oil + grapeseed oil with massage), Method 2 (grapeseed oil with massage), and Method 3 (control group - no oil or massage). Within the 15 minutes following oil application/massage
See also
  Status Clinical Trial Phase
Recruiting NCT03868137 - Multi-dose Ibuprofen Prophylaxis for IUD-insertion N/A
Completed NCT04539899 - Evaluation of the Influence of the Virtual Reality Helmet on Pain During IUD Insertion N/A
Recruiting NCT06023849 - Trans Caesarean Intra Uterine Contraceptive Device Insertion Versus Conventional Postpartum 6 Weeks Insertion N/A
Completed NCT04932382 - Misoprostol Prior to Intrauterine Device Insertion N/A
Completed NCT05383924 - Intrauterine Contraceptive Device Insertion During Cesarean Section (CS) Versus Delayed Insertion N/A
Completed NCT04389021 - Virtual Reality Simulation for Intrauterine Device Insertion: A Randomized Clinical Trial N/A
Completed NCT05187078 - Allis Clamp Versus Single-tooth Tenaculum N/A
Recruiting NCT05339555 - IUD Self-Removal Study N/A
Completed NCT04379102 - The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application
Recruiting NCT05875571 - Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement Phase 4
Active, not recruiting NCT02076217 - Quick Start of Highly Effective Contraception
Recruiting NCT05700812 - IUD Placement Without Sounding N/A
Recruiting NCT05252117 - Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research. Phase 4
Not yet recruiting NCT05471362 - Barriers of Immediate Postpartum Intrauterine Device Uptake
Not yet recruiting NCT04630548 - Safety and Efficacy of Immediate Post Placental IUD Insertion in Patients Undergoing Cesarean Delivery N/A
Not yet recruiting NCT05283798 - Insertion of Copper T380 Versus Multiload IUD Post Partum N/A
Not yet recruiting NCT06240260 - TENS Unit for Analgesia During IUD Insertion N/A
Completed NCT06042556 - IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings N/A